Molecular detection of chromosome aberrations
AssigneeErasmus Universiteit Rotterdam
InventorsJacobus Johannus Maria van Dongen, Anthonie Willem Langerak
Life of this patent
Estimating the term…
Abstract
The invention relates to the field of cytogenetics and the application of genetic diagnostic techniques in pathology and hematology. Specifically, the invention relates to nucleic acid probes that can be used in hybridization techniques for the detection of chromosomal aberrations and other gene rearrangements such as immunoglobulin and T cell receptor gene rearrangements. The probes provided by the invention are a distinct and balanced set of probes of comparable size each preferably being from 1 to 100 kb, or smaller, and flanking a potential breakpoint in a chromosome.
Claims10
A method of detecting a acid molecule having a chromosomal aberration, said method comprising:
- providing a pair of nucleic acid probes to detect chromosomal aberrations in hematological malignancies and to analyze a sample believed to contain said nucleic acid, said pair of nucleic acid probes having comparable size, said size being selected from the group consisting of 1 to 100 kb, 1 to 10 kb, 7 to 15 kb, 10 to 20 kb, 10 to 30 kb, 20 to 40 kb, 30 to 50 kb, 40 to 60 kb, 50 to 70 kb, 60 to 80 kb, 70 to 90 kb and 80 to 100 kb, and said pair of nucleic acid probes flanking a potential breakpoint in a single chromosome, each of said pair of nucleic acid probes being labeled with at least one different reporter molecule;
- hybridizing said pair of nucleic acid probes to said nucleic acid;
- and
- detecting the presence of a split signal that arises after a break within said potential breakpoint in the case of chromosomal aberration.
A method of detecting cells suspected of having a chromosomal aberration, said method comprisng:
- providing a pair of nucleic acid probes to detect chromosomal aberrations in hematological malignancies and to analyze nucleic acid of said cells, said pair of nucleic acid probes having comparable size, said size being selected from the group consisting of 1 to 100 kb, 1 to 10 kb, 7 to 15 kb, 10 to 20 kb, 10 to 30 kb, 20 to 40 kb, 30 to 50 kb, 40 to 60 kb, 50 to 70 kb, 60 to 80 kb, 70 to 90 kb and 80 to 100 kb, and said pair of nucleic acid probes flanking a potential breakpoint in a single chromosome, each of said pair of nucleic acid probes being labeled with at least one different reporter molecule;
- hydridizing said pair of nucleic acid probes to the nucleic acid of at least one of said cells;
- and
- detecting the presence of a split signal that arises after a break within said potential breakpoint in the case of a chromosomal aberration.
A method of detecting a break within a potential breakpoint of a single chromosome, said method comprising:
- associating a pair of nucleic acid probes for detection of chromosome aberrations in
- hematological malignancies and a sample believed to contain nucleic acid complimentary to said pair of nucleic acid probes, said pair of nucleic acid probes having comparable size, said size being selected from the group consisiting of 1 to 100 kb, 1 to 10 kb, 7 to 15 kb, 10 to 20 kb, 10 to 30 kb, 20 to 40 kb, 30 to 50 kb, 40 to 60 kb, 50 to 70 kb, 60 to 80 kb, 70 to 90 kb and 80 to 100 kb, each nucleic acid probe of said pair of nucleic acid probes being labeled with at least one different reporter molecule and flanking a potential breakpoint in said single chromosome;
- hybridizing said pair of nucleic acid probes to said nucleic acid;
- and
- determining whether a split-signal that arises after a break within said potential breakpoint in the case of chromosomal aberrations is present in said sample.
Dependencies are inferred from the claim text.